DE69131992D1 - Papillomavirusuntereinheit-impfstoff - Google Patents
Papillomavirusuntereinheit-impfstoffInfo
- Publication number
- DE69131992D1 DE69131992D1 DE69131992T DE69131992T DE69131992D1 DE 69131992 D1 DE69131992 D1 DE 69131992D1 DE 69131992 T DE69131992 T DE 69131992T DE 69131992 T DE69131992 T DE 69131992T DE 69131992 D1 DE69131992 D1 DE 69131992D1
- Authority
- DE
- Germany
- Prior art keywords
- papillomavirus
- sequence
- vaccine
- drahyni
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241001631646 Papillomaviridae Species 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 241000701806 Human papillomavirus Species 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 241000341655 Human papillomavirus type 16 Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229960002566 papillomavirus vaccine Drugs 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPK387690 | 1990-12-12 | ||
PCT/AU1991/000575 WO1992010513A1 (en) | 1990-12-12 | 1991-12-12 | Subunit papillomavirus vaccine and peptides for use therein |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69131992D1 true DE69131992D1 (de) | 2000-03-23 |
DE69131992T2 DE69131992T2 (de) | 2000-06-29 |
Family
ID=3775135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69131992T Expired - Lifetime DE69131992T2 (de) | 1990-12-12 | 1991-12-12 | Papillomavirusuntereinheit-impfstoff |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0561885B1 (de) |
JP (1) | JPH06503559A (de) |
KR (1) | KR100252371B1 (de) |
AT (1) | ATE189818T1 (de) |
CA (1) | CA2097916C (de) |
DE (1) | DE69131992T2 (de) |
WO (1) | WO1992010513A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8062642B1 (en) | 1993-03-09 | 2011-11-22 | University Of Rochester | Production of papillomavirus capsid protein and virus-like particles |
US6153201A (en) * | 1993-03-09 | 2000-11-28 | University Of Rochester | Oral immunization with papillomavirus virus-like particles |
AUPN015794A0 (en) | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
US6183746B1 (en) * | 1997-10-09 | 2001-02-06 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
DE19819476C1 (de) * | 1998-04-30 | 2000-01-05 | Deutsches Krebsforsch | Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins |
DE19925199A1 (de) | 1999-06-01 | 2000-12-07 | Medigene Ag | Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie |
DE19925235A1 (de) | 1999-06-01 | 2000-12-07 | Medigene Ag | Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie |
ES2519043T3 (es) | 2000-12-08 | 2014-11-06 | Academisch Ziekenhuis Leiden | Péptidos largos de 22-45 residuos de aminoácidos que inducen y/o mejoran las respuestas inmunológicas específicas para antígenos |
EP1288292A1 (de) * | 2001-08-31 | 2003-03-05 | Leids Universitair Medisch Centrum | Lange Peptiden die 22-40 Aminosäuren enthalten und die eine immunspezifische Immunantwort induzieren |
US20040151723A1 (en) * | 2001-06-08 | 2004-08-05 | Hiroo Maeda | Novel epitope of human papilloma virus e7 antigen and cd4-positive t cells activated by the epitope |
CA2523032A1 (en) | 2005-10-07 | 2007-04-07 | Immunovaccine Technologies Inc. | Vaccines for cancer therapy |
CU23674A1 (es) | 2007-07-31 | 2011-05-27 | Ct Ingenieria Genetica Biotech | Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica |
EP2197497B1 (de) | 2007-09-27 | 2016-06-01 | ImmunoVaccine Technologies Inc. | Verwendung von liposomen in einem träger mit einer kontinuierlichen hydrophoben phase zur abgabe von polynucleotiden in vivo |
CN102056622B (zh) | 2008-06-05 | 2016-04-06 | 免疫疫苗技术有限公司 | 包含脂质体、抗原、多核苷酸和含疏水物质的连续相的载体的组合物 |
BR112014007927B1 (pt) | 2011-10-06 | 2021-04-13 | Immunovaccine Technologies Inc | Composições de lipossoma compreendendo um adjuvante e usos das referidas composições e usos das referidas composições |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2641081A1 (de) * | 1988-12-23 | 1990-06-29 | Medgenix Group | |
PT97073A (pt) * | 1990-03-20 | 1991-10-31 | Behringwerke Ag | Processo para a preparacao de epitopos soro-reactivos de proteinas de papillomavirus 16 humano (hpv) |
EP0523391B1 (de) * | 1991-07-13 | 2003-03-19 | Dade Behring Marburg GmbH | Verwendung von HPV-16 E6 und E7-Gen gewonnen Peptiden für den diagnostischen Zweck |
-
1991
- 1991-12-12 WO PCT/AU1991/000575 patent/WO1992010513A1/en active IP Right Grant
- 1991-12-12 AT AT92900509T patent/ATE189818T1/de not_active IP Right Cessation
- 1991-12-12 CA CA002097916A patent/CA2097916C/en not_active Expired - Lifetime
- 1991-12-12 DE DE69131992T patent/DE69131992T2/de not_active Expired - Lifetime
- 1991-12-12 JP JP4501607A patent/JPH06503559A/ja not_active Ceased
- 1991-12-12 EP EP92900509A patent/EP0561885B1/de not_active Expired - Lifetime
- 1991-12-12 KR KR1019930701718A patent/KR100252371B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH06503559A (ja) | 1994-04-21 |
WO1992010513A1 (en) | 1992-06-25 |
EP0561885A4 (en) | 1994-09-21 |
DE69131992T2 (de) | 2000-06-29 |
KR100252371B1 (ko) | 2000-05-01 |
EP0561885A1 (de) | 1993-09-29 |
CA2097916A1 (en) | 1992-06-13 |
EP0561885B1 (de) | 2000-02-16 |
CA2097916C (en) | 2001-08-21 |
ATE189818T1 (de) | 2000-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69131992D1 (de) | Papillomavirusuntereinheit-impfstoff | |
MX2022010118A (es) | Peptidos y proteinas de dise?o para la deteccion, la prevencion y el tratamiento de la enfermedad por coronavirus de 2019 (covid-19). | |
DK0593754T3 (da) | Peptider fra humant papillomavirus til anvendelse i præparater til induktion af humant T-celle respons | |
BR9814487A (pt) | "vacina" | |
FR07C0073I2 (fr) | Vaccin contre le papillomavirus | |
BR9814606A (pt) | Formulação de vacina e métodos de tratamento de um indivìduo infectado com um vìrus hpv e de prevenção de infecção por papiloma vìrus | |
MA24638A1 (fr) | Vaccin | |
DE69206631D1 (de) | Impfstoff gegen das Fortpflanzungs- und Atmungssyndrom bei Schweinen (PRRS) und Diagnose. | |
MXPA02005639A (es) | Induccion de respuestas celulares iinmunologicas al virus de papiloma humano y utilizacion de composiciones de peptidos y acidos nucleico. | |
HUP0301308A2 (hu) | Emberi Papillomavírus-fertőzés gyógykezelése | |
DE59608274D1 (de) | Cyclosporin-derivate mit anti-hiv-wirkung | |
HUP0303942A2 (hu) | Új vakcinakészítmények | |
HUP9904171A2 (hu) | A ragadós száj- és körömfájás vírusok immunogén peptidjei | |
ATE193974T1 (de) | Chlamydia impfstoffen | |
HUP0202770A2 (hu) | Humán papillómavírus oltóanyag | |
DK0762895T3 (da) | Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus | |
NZ295056A (en) | Hepatitis virus e strain, recombinant proteins thereof, use in diagnostic methods and vaccines | |
WO1999024466A3 (en) | Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes | |
DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
EP0808846A3 (de) | Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |